April 9, 2021


Ames woman denied coverage for $16K prescription, insurance says it’s because bloodwork wasn’t done during pandemic

Sara Willette feels her insurance company is forcing her to choose between getting exposed to COVID, which could kill her, or going without a lifesaving therapy.

AMES, Iowa — An Ames woman is fighting to get a lifesaving medication after insurance told her pharmacy they weren’t going to cover it anymore.

The medicine costs more than $10,000 a month, a price Sara Willette said she can’t afford to pay.

“It’s saddening, it’s frustrating and it’s completely unnecessary,” Willette said. “It’s a novel virus pandemic out there. We shouldn’t be sending high-risk people in when it’s not safe yet.”

Willette’s health

Read More

Stop Blacklisting Republicans Who Denied Joe Biden’s Election Win, Business Leaders Say

The U.S. Chamber of Commerce has said corporations should be willing to donate to Republicans in Congress who voted against certifying the Electoral College victory of President Joe Biden on January 6.

In the wake of the Capitol right, some large corporations reconsidered donations to Republicans who had supported decertifying the votes that confirmed Biden as president. Companies that suspended political donations to objectors indefinitely included AT&T, Comcast, Amazon and Home Depot, according to a CNN report on February 21.

Other firms, like Lockheed Martin, Boeing and Raytheon Technologies, suspended donations to all federal candidates. Details about the companies’ plans

Read More

Investors Eye Windfall From Denied COVID-19 Insurance Claims

A growing market niche where investors profit from others’ legal troubles is getting a boost from Covid.

Distressed-investing funds and litigation-finance boutiques are likely to be spoiled for choice after a landmark U.K. court ruling last month rejected pleas from insurers looking to dodge pandemic payouts. They’re looking to finance or buy denied Covid-19 insurance claims for policyholders without the means or stomach for taking their insurers to court.

“This is going to be huge,” said Steve Cooklin, chief executive officer of London-based litigation funder Manolete Partners Plc, whose biggest shareholder is veteran distressed investor Jon Moulton. “It’s hard to

Read More